Dexamethasone&#44

3 trials

Sponsors

Department of Orthopaedics Faculty of Medicine Chiang Mai University, Thai Medical Association

Conditions

Degenerative lumbar spinePain Opioid consumptiom Survaval ratePatient with cancer who will receive high dose cisplatin chemotherapy. Age â‰¥ 18 years old no previously treat with chemotherapy NK1 receptor antagonist Serotonin receptor antagonist Netupitant Palonosetron High emetic chemotherapy(HEC)

Phase 1

Prospective study comparing quality of life between opioids sparing protocol and WHO guideline in metastatic bone cancer

RecruitingTCTR20180503005

Thai Medical AssociationPain Opioid consumptiom Survaval rate

Start: 2018-01-23Target: 240Updated: 2026-03-30

Phase 2

Equivalency study of novel current standard 3-drugs combination regimen (ondansetron, dexamethasone and olanzapine) to netupitant containing regimen for preventing high dose cisplatin induce nausea and vomiting treatment, double blind placebo control trial

RecruitingTCTR20190508001

Patient with cancer who will receive high dose cisplatin chemotherapy. Age â‰¥ 18 years old no previously treat with chemotherapy NK1 receptor antagonist Serotonin receptor antagonist Netupitant Palonosetron High emetic chemotherapy(HEC)

Start: 2019-04-01Target: 100Updated: 2026-03-30

Phase 4

Effectiveness of Perioperative Dexamethasone and Bupivacaine for Reducing Postoperative Pain in Posterior Lumbosacral Spine Surgery: A preliminary randomized double blind placebo-controlled trial

Active, not recruitingTCTR20170807002

Department of Orthopaedics Faculty of Medicine Chiang Mai UniversityDegenerative lumbar spine

Start: 2015-08-03Updated: 2026-03-30

Related Papers

The equivalency study of novel current standard 3-drugs combination regimen (ondansetron, dexamethasone and olanzapine) to netupitant containing regimen for preventing high dose cisplatin induce nausea and vomiting treatment, double blind placebo control trial.

Journal of Clinical Oncology2021-05-20